Foundation board member and district governor Michael Brandl, Monika Brandl, Ernst Brandl’s widow, award winner Chiara Herzog, Vice Provost of University Innsbruck, Gregor Weihs, and mayor of the city of Schwaz, Mayor Victoria Weber.
Chiara Herzog honored with Ernst Brandl Award for WID®-easy Test
Dr. Chiara Herzog, head of bioinformatics at the European Translational Oncology Prevention & Screening Institute, headed by Martin Widschwendter, was honored with the Ernst Brandl Award for her work on developing and validating the WID®-easy Test.
Foundation board member and district governor Michael Brandl, Monika Brandl, Ernst Brandl’s widow, award winner Chiara Herzog, Vice Provost of University Innsbruck, Gregor Weihs, and mayor of the city of Schwaz, Mayor Victoria Weber.
The Ernst Brandl Award
Professor Ernst Brandl from Schwaz achieved world fame by discovering penicillin V (penicillin in tablet form), thus positively changing the pharmaceutical industry. The foundation he established still supports social institutions today and honors scientific achievements with the Ernst Brandl Award, which is highly regarded among experts.
This year’s ceremony of the Ernst Brandl Foundation took place on May 10 in the City Hall of Schwaz. Mayor Victoria Weber welcomed the foundation’s board of directors District Governor Michael Brandl, Monika Brandl, Ernst Brandl’s widow, Vice Rector Gregor Weihs and Martin Widschwendter, Professor of Cancer Prevention and Screening at the University of Innsbruck.
The laureate Chiara Herzog
This year, Chiara Herzog was awarded the Ernst Brandl Prize, worth € 4,000, for her work on developing and validating the development and validation of the WID®-easy Test for detecting endometrial cancer. The novel test aims to make detecting this type of cancer more robust, objective and faster.
“The new method, which is already in practical use, thus makes a significant contribution to the well-being of people entirely in line with the foundation’s idea and is therefore highly worthy of an award.”
Chiara Herzog conducts research at the European Translational Oncology Prevention & Screening Institute (EUTOPS), which Martin Widschwendter heads. He also received the Ernst Brandl Prize in 1999.
A native of Tyrol, she joined the EUTOPS Institute in 2020 and has since been a leader in research on epigenetics in cancer development and prevention, as well as in healthy aging and longevity. Her work has been published in numerous prestigious journals, e.g., Journal of Clinical Oncology, Nature Communications, Cell, Nature Medicine or THE LANCET Oncology.